↓ Skip to main content

Phase II study of two dose schedules of C.E.R.A. (Continuous Erythropoietin Receptor Activator) in anemic patients with advanced non-small cell lung cancer (NSCLC) receiving chemotherapy

Overview of attention for article published in Trials, March 2007
Altmetric Badge

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
30 Mendeley